These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. First one-day, oral antiviral for cold sores is approved. Dent Assist; 2003; 72(6):45. PubMed ID: 14705406 [No Abstract] [Full Text] [Related]
12. Oral antivirals for the acute treatment of recurrent herpes labialis. Jensen LA; Hoehns JD; Squires CL Ann Pharmacother; 2004 Apr; 38(4):705-9. PubMed ID: 14966254 [TBL] [Abstract][Full Text] [Related]
13. High-dose, short-duration, early valacyclovir therapy for episodic treatment of cold sores: results of two randomized, placebo-controlled, multicenter studies. Spruance SL; Jones TM; Blatter MM; Vargas-Cortes M; Barber J; Hill J; Goldstein D; Schultz M Antimicrob Agents Chemother; 2003 Mar; 47(3):1072-80. PubMed ID: 12604544 [TBL] [Abstract][Full Text] [Related]
14. Clinical significance of antiviral therapy for episodic treatment of herpes labialis: exploratory analyses of the combined data from two valaciclovir trials. Spruance SL; Hill J J Antimicrob Chemother; 2004 May; 53(5):703-7. PubMed ID: 15044423 [TBL] [Abstract][Full Text] [Related]
15. Valacyclovir and topical clobetasol gel for the episodic treatment of herpes labialis: a patient-initiated, double-blind, placebo-controlled pilot trial. Hull C; McKeough M; Sebastian K; Kriesel J; Spruance S J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):263-7. PubMed ID: 19143902 [TBL] [Abstract][Full Text] [Related]
16. Valacyclovir HCl (Valtrex): an acyclovir prodrug with improved pharmacokinetics and better efficacy for treatment of zoster. Smiley ML; Murray A; de Miranda P Adv Exp Med Biol; 1996; 394():33-9. PubMed ID: 8815698 [No Abstract] [Full Text] [Related]